178 related articles for article (PubMed ID: 2450688)
1. Regulation of natural killer activity.
Ortaldo JR
Cancer Metastasis Rev; 1987; 6(4):637-51. PubMed ID: 2450688
[TBL] [Abstract][Full Text] [Related]
2. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
Reiter Z
J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
[TBL] [Abstract][Full Text] [Related]
3. Behaviorally conditioned modulation of natural killer cell activity: enhancement of baseline and activated natural killer cell activity.
Gee AL; Thiele GM; Johnson DR
Int J Neurosci; 1994 Jul; 77(1-2):139-52. PubMed ID: 7527380
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative regulation of Natural Killer cells: therapeutic implications.
Hallett WH; Murphy WJ
Semin Cancer Biol; 2006 Oct; 16(5):367-82. PubMed ID: 16934486
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA
Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360
[TBL] [Abstract][Full Text] [Related]
6. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Bonavida B; Nio Y; Yoshida O
Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21 induces proliferation and modulates receptor expression and effector function in canine natural killer cells.
Shin DJ; Lee SH; Park JY; Kim JS; Lee JJ; Suh GH; Lee YK; Cho D; Kim SK
Vet Immunol Immunopathol; 2015 May; 165(1-2):22-33. PubMed ID: 25819349
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.
Falk CS; Steinle A; Schendel DJ
J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674
[TBL] [Abstract][Full Text] [Related]
10. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory effects of cytokines on natural killer cells.
Naume B; Espevik T
Scand J Immunol; 1994 Aug; 40(2):128-34. PubMed ID: 8047834
[TBL] [Abstract][Full Text] [Related]
12. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
13. Immunosenescence of human natural killer cells.
Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R
J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928
[TBL] [Abstract][Full Text] [Related]
14. Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity.
Nirmala R; Narayanan PR; Mathew R; Maran M; Deivanayagam CN
Tuberculosis (Edinb); 2001; 81(5-6):343-52. PubMed ID: 11800585
[TBL] [Abstract][Full Text] [Related]
15. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells.
Correa I; Corral L; Raulet DH
Eur J Immunol; 1994 Jun; 24(6):1323-31. PubMed ID: 8206092
[TBL] [Abstract][Full Text] [Related]
16. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
17. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
[TBL] [Abstract][Full Text] [Related]
18. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
19. Induction of the nitric oxide-synthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells.
Cifone MG; Festuccia C; Cironi L; Cavallo G; Chessa MA; Pensa V; Tubaro E; Santoni A
Cell Immunol; 1994 Aug; 157(1):181-94. PubMed ID: 7518750
[TBL] [Abstract][Full Text] [Related]
20. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
